| Donna Ransom, CRNA | |
|
4420 Lake Boone Trl, Raleigh, NC 27607-7505 | |
| (919) 784-3034 | |
| Not Available |
| Full Name | Donna Ransom |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 27 Years |
| Location | 4420 Lake Boone Trl, Raleigh, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003960667 | NPI | - | NPPES |
| 430037045 | Other | NC | RAILROAD-MEDICARE |
| 8051018 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 48598 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Duke Health Raleigh Hospital | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke Health Integrated Practice Inc | 8325412737 | 2551 |
News Archive
Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention of using RNA-guided endonucleases, such as Cas9 or Cpf1 for the genetic engineering of T-cells.
Lung cancer patients are particularly susceptible to malignant pleural effusion, when fluid collects in the space between the lungs and the chest wall. Researchers at the Helmholtz Zentrum München, in partnership with the German Center for Lung Research, have discovered a novel mechanism that causes this to happen.
Researchers at the University of Buffalo and University of California, Irvine, found a connection between people being nice and versions of receptor genes for two hormones, oxytocin and vasopressin, that have been associated with niceness in past studies.
The National Fragile X Foundation has awarded a translational research seed grant of $100,000 to Dr. Randi J. Hagerman at the UC Davis M.I.N.D. Institute in California for a study of minocycline in the treatment of children with fragile X syndrome (FXS). Hagerman is an internationally recognized clinician and clinical researcher on FXS, the most common cause of inherited mental impairment.
Every day, people suffer traumatic experiences that scar their minds. Combat, rape, bombings, burns, beatings, and horrific car accidents haunt them with memories impossible to suppress. Such day- and nightmares are part of a problem known as post-traumatic stress disorder, or PTSD.
› Verified 4 days ago
| Entity Name | American Anesthesiology Of North Carolina Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053677195 PECOS PAC ID: 2961316450 Enrollment ID: O20031229000004 |
News Archive
Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention of using RNA-guided endonucleases, such as Cas9 or Cpf1 for the genetic engineering of T-cells.
Lung cancer patients are particularly susceptible to malignant pleural effusion, when fluid collects in the space between the lungs and the chest wall. Researchers at the Helmholtz Zentrum München, in partnership with the German Center for Lung Research, have discovered a novel mechanism that causes this to happen.
Researchers at the University of Buffalo and University of California, Irvine, found a connection between people being nice and versions of receptor genes for two hormones, oxytocin and vasopressin, that have been associated with niceness in past studies.
The National Fragile X Foundation has awarded a translational research seed grant of $100,000 to Dr. Randi J. Hagerman at the UC Davis M.I.N.D. Institute in California for a study of minocycline in the treatment of children with fragile X syndrome (FXS). Hagerman is an internationally recognized clinician and clinical researcher on FXS, the most common cause of inherited mental impairment.
Every day, people suffer traumatic experiences that scar their minds. Combat, rape, bombings, burns, beatings, and horrific car accidents haunt them with memories impossible to suppress. Such day- and nightmares are part of a problem known as post-traumatic stress disorder, or PTSD.
› Verified 4 days ago
| Entity Name | Regional Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952486946 PECOS PAC ID: 3779681408 Enrollment ID: O20070604000698 |
News Archive
Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention of using RNA-guided endonucleases, such as Cas9 or Cpf1 for the genetic engineering of T-cells.
Lung cancer patients are particularly susceptible to malignant pleural effusion, when fluid collects in the space between the lungs and the chest wall. Researchers at the Helmholtz Zentrum München, in partnership with the German Center for Lung Research, have discovered a novel mechanism that causes this to happen.
Researchers at the University of Buffalo and University of California, Irvine, found a connection between people being nice and versions of receptor genes for two hormones, oxytocin and vasopressin, that have been associated with niceness in past studies.
The National Fragile X Foundation has awarded a translational research seed grant of $100,000 to Dr. Randi J. Hagerman at the UC Davis M.I.N.D. Institute in California for a study of minocycline in the treatment of children with fragile X syndrome (FXS). Hagerman is an internationally recognized clinician and clinical researcher on FXS, the most common cause of inherited mental impairment.
Every day, people suffer traumatic experiences that scar their minds. Combat, rape, bombings, burns, beatings, and horrific car accidents haunt them with memories impossible to suppress. Such day- and nightmares are part of a problem known as post-traumatic stress disorder, or PTSD.
› Verified 4 days ago
| Entity Name | Duke Health Integrated Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention of using RNA-guided endonucleases, such as Cas9 or Cpf1 for the genetic engineering of T-cells.
Lung cancer patients are particularly susceptible to malignant pleural effusion, when fluid collects in the space between the lungs and the chest wall. Researchers at the Helmholtz Zentrum München, in partnership with the German Center for Lung Research, have discovered a novel mechanism that causes this to happen.
Researchers at the University of Buffalo and University of California, Irvine, found a connection between people being nice and versions of receptor genes for two hormones, oxytocin and vasopressin, that have been associated with niceness in past studies.
The National Fragile X Foundation has awarded a translational research seed grant of $100,000 to Dr. Randi J. Hagerman at the UC Davis M.I.N.D. Institute in California for a study of minocycline in the treatment of children with fragile X syndrome (FXS). Hagerman is an internationally recognized clinician and clinical researcher on FXS, the most common cause of inherited mental impairment.
Every day, people suffer traumatic experiences that scar their minds. Combat, rape, bombings, burns, beatings, and horrific car accidents haunt them with memories impossible to suppress. Such day- and nightmares are part of a problem known as post-traumatic stress disorder, or PTSD.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donna Ransom, CRNA 3100 Spring Forest Rd, Suite 130, Raleigh, NC 27616-2880 Ph: (919) 873-9533 | Donna Ransom, CRNA 4420 Lake Boone Trl, Raleigh, NC 27607-7505 Ph: (919) 784-3034 |
News Archive
Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention of using RNA-guided endonucleases, such as Cas9 or Cpf1 for the genetic engineering of T-cells.
Lung cancer patients are particularly susceptible to malignant pleural effusion, when fluid collects in the space between the lungs and the chest wall. Researchers at the Helmholtz Zentrum München, in partnership with the German Center for Lung Research, have discovered a novel mechanism that causes this to happen.
Researchers at the University of Buffalo and University of California, Irvine, found a connection between people being nice and versions of receptor genes for two hormones, oxytocin and vasopressin, that have been associated with niceness in past studies.
The National Fragile X Foundation has awarded a translational research seed grant of $100,000 to Dr. Randi J. Hagerman at the UC Davis M.I.N.D. Institute in California for a study of minocycline in the treatment of children with fragile X syndrome (FXS). Hagerman is an internationally recognized clinician and clinical researcher on FXS, the most common cause of inherited mental impairment.
Every day, people suffer traumatic experiences that scar their minds. Combat, rape, bombings, burns, beatings, and horrific car accidents haunt them with memories impossible to suppress. Such day- and nightmares are part of a problem known as post-traumatic stress disorder, or PTSD.
› Verified 4 days ago
Eric Linton, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4420 Lake Boone Trl, Raleigh, NC 27607 Phone: 919-784-3100 | |
Brianne V Schreiber, DNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4044 Barton Park Pl, Raleigh, NC 27613 Phone: 330-503-7009 | |
Carol Goodson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2308 Wesvill Ct, Raleigh, NC 27607 Phone: 919-781-4311 | |
Christopher Michael Lamers, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3000 New Bern Ave, Raleigh, NC 27610 Phone: 919-350-5645 | |
Douglas Sanks, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3000 New Bern Ave, Raleigh, NC 27610 Phone: 919-350-5645 | |
Angela L Kinmann, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3000 New Bern Ave, Raleigh, NC 27610 Phone: 919-350-5645 |